Physician

Michael A Geffin, MD

According to 2025 Medicare claims, Michael Geffin, MD (NPI: 1578583902) practices urology in the Boston, MA market, with the plurality of this provider's patient population coming from Plymouth, MA. This provider's primary affiliated billing organization is GREATER BOSTON UROLOGY, LLC (NPI: 1003120411; TIN: 272299847) and primary practice location at 02360-2669. Geffin is affiliated with the Lahey Clinical Performance ACO (ACO ID: A1490), participating under the MSSP model.

Geffin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,255 traditional Medicare patients, billed 18,862 HCPCS/CPT codes, and received $502,559 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,519 prescription claims across 647 beneficiaries totaling $622,751 in drug costs, led by Xtandi (Enzalutamide). DME data shows 132 claims. Open Payments data shows 40 records totaling $1,262. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $109,376 to $502,559. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $52,774 and ending at $622,751. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $789 to $328.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$270K$541K2015 Medicare payment: $109,376 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $168,711 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $502,514 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $502,477 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $482,372 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $461,896 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $540,536 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $481,355 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $483,376 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $502,559 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20153602,004$109,376
20164712,776$168,711
20174883,321$502,514
20186584,708$502,477
20191,23810,103$482,372
20201,08210,854$461,896
20211,14011,830$540,536
20221,11511,159$481,355
20231,12513,970$483,376
20241,25518,862$502,559

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$466K$933K2015 Drug cost: $52,774 (USD; Tot_Drug_Cst)2016 Drug cost: $138,097 (USD; Tot_Drug_Cst)2017 Drug cost: $326,029 (USD; Tot_Drug_Cst)2018 Drug cost: $475,095 (USD; Tot_Drug_Cst)2019 Drug cost: $932,948 (USD; Tot_Drug_Cst)2020 Drug cost: $598,946 (USD; Tot_Drug_Cst)2021 Drug cost: $222,760 (USD; Tot_Drug_Cst)2022 Drug cost: $209,159 (USD; Tot_Drug_Cst)2023 Drug cost: $581,845 (USD; Tot_Drug_Cst)2024 Drug cost: $622,751 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152771,113$52,774
2016236899$138,097
2017248966$326,029
2018284968$475,095
20195091,750$932,948
20205192,074$598,946
20215902,307$222,760
20225982,160$209,159
20236292,352$581,845
20246472,519$622,751

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$39K$78K2015 Medicare payment: $3,668 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $2,565 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $2,167 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $6,875 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $17,623 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $53,285 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $69,135 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $63,097 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $77,607 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R26$3,668
2016N/R13$2,565
2017N/RN/RN/R
2018N/R12$2,167
2019N/R30$6,875
2020N/R90$17,623
2021N/R127$53,285
2022N/R125$69,135
2023N/R90$63,097
2024N/R132$77,607

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more7491,220$94
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more403530$66
36415Insertion of needle into vein for collection of blood sample359509$9
51798Ultrasound measurement of bladder capacity after voiding628897$9
81003Automated urinalysis test344401$2

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
XtandiEnzalutamide14420$177,000
NubeqaDarolutamide13390$174,527
GemtesaVibegron996,270$97,965
MyrbetriqMirabegron905,309$76,647
OrgovyxRelugolix12360$32,149

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
A4352Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), eachNN/R43$51,183
A4351Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), eachNN/R63$25,870
A4357Bedside drainage bag, day or night, with or without anti-reflux device, with or without tube, eachNN/R14$344
A4332Lubricant, individual sterile packet, eachNN/R12$209

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.40$1,262DENTSPLY IH AB
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Michael A. Geffin, MD?

Tedicare shows public-source Medicare data for Michael A. Geffin, MD (NPI 1578583902), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael A. Geffin, MD have ACO affiliation data?

Michael A. Geffin, MD is shown with ACO affiliation data for Lahey Clinical Performance ACO (MSSP, ACO ID A1490).

What billing organization is linked to Michael A. Geffin, MD?

Michael A. Geffin, MD is linked to GREATER BOSTON UROLOGY, LLC (billing NPI 1003120411) in the available physician profile data.

Does Michael A. Geffin, MD have Open Payments data?

Michael A. Geffin, MD has 40 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.